Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Cheng

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Plos One|June 23, 2021
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysisNiklas Bobrovitz, Rahul Krishan Arora, Christian Cao, et al.
CMAJ Open|April 20, 2022
Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort studyTerry Lee, Matthew P Cheng, Donald C Vinh, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Journal of Proteome Research|February 10, 2022
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19Yassene Mohammed, David R Goodlett, Matthew P Cheng, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Journal of Innate Immunity|December 3, 2024
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19Greg Haljan, Terry Lee, Anne McCarthy, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Journal of Proteome Research|December 4, 2023
Proteomic Evolution from Acute to Post-COVID-19 ConditionsYassene Mohammed, Karen Tran, Chris Carlsten, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Plos One|June 23, 2021
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysisNiklas Bobrovitz, Rahul Krishan Arora, Christian Cao, et al.
CMAJ Open|April 20, 2022
Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort studyTerry Lee, Matthew P Cheng, Donald C Vinh, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Journal of Proteome Research|February 10, 2022
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19Yassene Mohammed, David R Goodlett, Matthew P Cheng, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Journal of Innate Immunity|December 3, 2024
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19Greg Haljan, Terry Lee, Anne McCarthy, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Trials|February 11, 2025
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trialRobert K Mahar, Anna McGlothlin, Michael Dymock, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Journal of Proteome Research|December 4, 2023
Proteomic Evolution from Acute to Post-COVID-19 ConditionsYassene Mohammed, Karen Tran, Chris Carlsten, et al.
Pageof 16